Literature DB >> 17659845

Cognitive functioning in polycystic ovary syndrome.

L Barnard1, A H Balen, D Ferriday, B Tiplady, L Dye.   

Abstract

To date there have been no published studies of cognitive functioning in polycystic ovary syndrome (PCOS). This large internet-based study compared neuropsychological functioning in right-handed women with (minimum n=135) and without PCOS (minimum n=322), stratified according to use of anti-androgen medication and level of depression. Women with PCOS are thought to have hyperandrogenism and hyperestrogenism which was hypothesized to differentially influence cognitive function across cognitive domains. Performance did not differ according to diagnosis on mental rotation and spatial location tasks. Hence, no evidence to support the view that women with PCOS display a more masculine cognitive profile due to hyperandrogenism. Despite presumed hyperestrogenism, women with PCOS demonstrated impaired performance in terms of speed and accuracy, on reaction time and word recognition tasks. These findings are intriguing given the well-documented roles of estrogen and testosterone in cognitive function. Overall, these findings suggest that PCOS is not associated with masculinized cognitive functioning, and, although associated with impaired performance on tasks considered to demonstrate female-advantage, such impairments are subtle and are unlikely to affect daily functioning.

Entities:  

Mesh:

Year:  2007        PMID: 17659845     DOI: 10.1016/j.psyneuen.2007.06.010

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  8 in total

Review 1.  Luteinizing hormone: Evidence for direct action in the CNS.

Authors:  Jeffrey A Blair; Sabina Bhatta; Henry McGee; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-07-12       Impact factor: 3.587

2.  Luteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing.

Authors:  Jeffrey A Blair; Russell Palm; Jaewon Chang; Henry McGee; Xiongwei Zhu; Xinglong Wang; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-10-21       Impact factor: 3.587

3.  Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance.

Authors:  Christian-Alexandre Castellano; Jean-Patrice Baillargeon; Scott Nugent; Sébastien Tremblay; Mélanie Fortier; Hélène Imbeault; Julie Duval; Stephen C Cunnane
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

4.  Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation.

Authors:  Michael J Boivin; Farnaz Fatehi; Amy E Phillips-Chan; Julia R Richardson; Amanda N Summers; Steven A Foley
Journal:  BMC Womens Health       Date:  2020-06-23       Impact factor: 2.809

5.  Association of acne, hirsutism, androgen, anxiety, and depression on cognitive performance in polycystic ovary syndrome: A cross-sectional study.

Authors:  Saeideh Mehrabadi; Shahideh Jahanian Sadatmahalleh; Anoshirvan Kazemnejad; Ashraf Moini
Journal:  Int J Reprod Biomed       Date:  2020-12-21

6.  Changes in Resting-State Cerebral Activity in Women With Polycystic Ovary Syndrome: A Functional MR Imaging Study.

Authors:  Guanghui Li; Junhao Hu; Si Zhang; Weijie Fan; Li Wen; Guangxian Wang; Dong Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-10       Impact factor: 5.555

7.  White Matter Microstructure and Cognitive Function in Young Women With Polycystic Ovary Syndrome.

Authors:  D Aled Rees; Maneesh Udiawar; Rok Berlot; Derek K Jones; Michael J O'Sullivan
Journal:  J Clin Endocrinol Metab       Date:  2015-11-17       Impact factor: 5.958

8.  Dysglycemia, Not Altered Sex Steroid Hormones, Affects Cognitive Function in Polycystic Ovary Syndrome.

Authors:  Brittany Y Jarrett; Natalie Vantman; Reid J Mergler; Eric D Brooks; Roger A Pierson; Donna R Chizen; Marla E Lujan
Journal:  J Endocr Soc       Date:  2019-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.